Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Pharmacology|January 5, 2026
Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapyVlad Andrei Cianga, Ion Antohe, Cosmin Minciună, et al.Frontiers in Oncology|April 2, 2020
B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk ProfilesIon Antohe, Angela Dǎscǎlescu, Cǎtǎlin Dǎnǎilǎ, et al.Immunobiology|December 22, 2020
The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expressionIon Antohe, Mariana Pavel Tanasa, Angela Dăscălescu, et al.Archive of Clinical Cases|November 10, 2021
A very rare case of FLT3-D835 positive blastic plasmacytoid dendritic cell neoplasmVlad Andrei Cianga, Cătălin Doru Dănăilă, Ion Antohe, et al.Journal of Clinical Medicine|November 27, 2025
Mortality Prediction in Diffuse Large B-Cell Lymphoma Using Supervised Machine Learning Models-A Retrospective StudyCosmin-Daniel Minciuna, Dorina Minciuna, Angela-Smaranda Dascalescu, et al.Journal of Clinical Medicine|May 4, 2026
Clinical, Biological, and Treatment-Related Predictors of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma: A Retrospective Cohort StudyCosmin-Daniel Minciuna, Dorina Minciuna, Angela-Smaranda Dascalescu, et al.Best Practice & Research. Clinical Haematology|September 7, 2025
Adoptive cellular therapies in multiple myelomaDavid Kegyes, Bogdan Borlea, Marc Damian, et al.Frontiers in Pharmacology|December 26, 2025
Real-world patient outcomes with Blinatumomab and Inotuzumab in adult relapsed/refractory B-cell acute lymphoblastic leukemia: a retrospective analysis from two Romanian oncology centersIon Antohe, Amalia Titieanu, Vlad Andrei Cianga, et al.Best Practice & Research. Clinical Haematology|September 7, 2025
Adoptive cellular therapies in non-Hodgkin lymphomasDavid Kegyes, Bogdan Borlea, Marc Damian, et al.Journal of Clinical Medicine|October 13, 2021
Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral LymphomaDalma Deak-Mihaly, Sabina Iluta, Sergiu Pasca, et al.Pageof 2